이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2021. 10. 6.1 분 읽기
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; Withdrawal
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is withdrawing the notice that published in the Federal Register of September 30, 2021, that announced the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Register notice was published in error and is being withdrawn.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →